Statin Induced Muscle Toxicity - Summary
Clinical Presentation:
• Elevations of serum creatine kinase with proximal myalgia and weakness without skin involvement
Epidemiology
• 10% to 15% of individuals on statin therapy experience Statin-Associated Muscle Symptoms (SAMS)
• 1 of 100,000 patients taking a statin, IMNM
Duration:
• The onset of muscle symptoms: weeks to months after the initiation of statin therapy / may occur at any time during treatment
Statin-Induced Myalgia/Myopathy Symptoms:
• Proximal symmetric muscle weakness
• Soreness
• Myalgia
• Myositis
• Rhabdomyolysis
• Difficulty raising the arms above the head, arising from a seated position, or climbing stairs
• Fatigue or tiredness
• Myoglobinuria
DDX:
• Inflammatory myopathy, rhabdomyolysis, toxic myopathy, hypothyroid-induced myopathy, Guillain-Barré syndrome (GBS), systemic lupus erythematosus (SLE), polymyositis, dermatomyositis, inclusion body myositis antisynthetase syndrome, immune-mediated necrotizing myopathy (IMNM), Lambert-Eaton myasthenic syndrome (LEMS), systemic sclerosis.
Statins → Inflammatory myopathies such as
• Statin-induced myopathy (SAMS) → Direct muscle injury
• Immune-mediated necrotizing myopathy (IMNM) → Antibodies to hydroxymethylglutaryl (HMG)-CoA reductase (HMGCR)
- Necrotizing myopathy: Inflammatory statin myopathy is characterized by a macrophagocytic infiltrate engulfing necrotic muscle fibers
Risk of myopathy appears to be lowest with:
• Fluvastatin
• Pravastatin
• Pitavastatin
Risk of muscle injury - Statins extensively metabolized by CYP3A4:
• Lovastatin
• Simvastatin
• Atorvastatin
Diagnosis:
• CK:
- SAMS <20,000 IU/I
- IMNM: 1,000–20,000 IU/I
• SAMS clinical index (SAMS-CI)
• EMG shows small-amplitude motor-unit potentials with increased spontaneous activity
• If statin-associated muscle symptoms (SAMS) fail to resolve after DC statin — then need to consider: immune-mediated necrotizing myopathy (IMNM)
• Muscle biopsy if symptoms do not resolve after DC Statin
Treatment:
• Stop statin
• Oral steroid, methotrexate, intravenous immunoglobulin (IVIG), and/or rituximab
#SAMS #Statin #muscle #toxicity #myopathy #diagnosis #management #treatment